Dennis M. Lanfear, President & CEO at Coherus BioSciences, Inc. (CHRS), sold 825,000 shares at $18.00 ($14.8M) on 2019-11-20, disclosed to the SEC on 2019-11-22.
Open-market sale of $14.8M CHRS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CHRS | SELL | 2019-11-25 | $464K | — | Filing → |
| CHRS | SELL | 2019-05-31 | $1.3M | — | Filing → |
| CHRS | SELL | 2018-05-17 | $682K | — | Filing → |